The Last Men (2023)

The film opens in the early 2000s with a series of conference-room scenes that follow a group of studio executives and producers as they discuss the possibility of adapting a famous comic-book arc. In 2000, the story flashes back to a different meeting in which a joint venture between a major comic publisher and an independent studio establishes a plan to develop a slate of on-screen heroes. Executives draw up dossiers and assign rights, and the plan to adapt at least fifteen characters to film takes form. Over the next few years, rights shift, corporate mergers and acquisitions alter priorities, and by 2003 the producers revisit the idea of bringing a particular cosmic-powered heroine's saga to the screen; they decide to treat that story as a subplot in a larger, already scheduled franchise installment. Writers and producers evaluate that treatment, and the film they assemble in that period integrates elements of the heroine's arc, but test audiences and internal feedback reject the version that folded an epic origin into a broader franchise entry.

The narrative then moves forward to 2009 and beyond, showing the studio corridors where rights revert and projects stall. In 2009, studio executives approve development of a different, self-contained film centered on a single antihero. The new project receives an initial budget allocation of roughly fifty to fifty-nine million dollars, and the production hires a visual-effects specialist making his first feature-length directorial debut. Screenwriters are contracted to produce a script that leans into R-rated humor and meta-commentary. Casting decisions follow: a well-known actor who had previously appeared briefly in franchise entries signs to play the title character. In March 2015 the crew assembles, they shoot for two months, and the film moves into post-production. A release is scheduled for February 2016. When the film reaches theaters, it outperforms expectations: domestic and international box-office receipts climb, and the picture finishes its run with approximately seven hundred eighty-three million dollars worldwide, making it the highest-grossing R-rated film at that time.

Parallel to that success, the story returns to the attempts to adapt the heroine's saga in earnest. A screenwriter begins drafting a fresh screenplay in 2016 that reimagines the heroine's transformation as an origin story and places emphasis on her deteriorating mental state. In the midst of pre-production, the studio changes leadership on the project: the filmmaker originally attached is removed and the screenwriter is elevated to the director's chair, a personnel change that becomes public in mid-2017. The new director and the cast rehearse and prepare to shoot a story that the filmmakers initially conceive as a two-part cinematic event. Near the end of pre-production, however, studio executives insist the filmmakers compress that planned two-part narrative into a single feature.

Principal photography for that film begins in June 2017 and runs through October of the same year. During the shoot, the production films extensive sequences portraying the heroine's escalating powers and the interpersonal fractures among the core ensemble. After principal photography wraps, the studio demands reshoots; negotiations over schedules and commitments occupy the next year because many of the cast members have accepted other projects, and the reshoot windows stretch the production calendar. The studio postpones the release several times while the filmmakers attempt to complete additional photography and post-production work. The resulting feature debuts in June 2019. Critics respond with widespread disapproval; reviews and public reaction scorn the film's execution. Financial accounting after the theatrical run shows the studio registering a loss of approximately one hundred thirty-three million dollars on that picture, and industry observers classify the release as one of the studio's largest box-office failures.

During the same era, the filmography of the franchise expands again when a separate filmmaker develops a horror-tinged entry that centers on a group of adolescents with extraordinary abilities. That director clashes repeatedly with studio executives over the tone and approach; the production notes show that the filmmaker resists mandated rewrites designed to shift the screenplay toward the executives' preferred vision. The studio issues orders for multiple rewrites, and the director declines to accept the imposed changes. Casting for this horror-tinged film brings together a young ensemble: an actress credited as Blu Hunt; another cast member who later rises to prominence, Anya Taylor-Joy; Charlie Heaton; Maisie Williams; and Henry Zaga. The production also casts an established actress, Alice Braga, in the role of the facility physician who oversees the captive teens. The crew shoots the film over the northern hemisphere summer of 2017, completing principal photography within that window. After shooting concludes, disagreements over the final cut and creative direction intensify. External corporate developments complicate matters further when the studio that owns the franchise enters into acquisition talks with a larger entertainment conglomerate.

The narrative turns to boardrooms and legal negotiations as it follows the studio's executives into merger discussions that begin in late 2017. The film depicts executives preparing strategy memos and financial models tied to the launch of a new global streaming service being developed by the potential acquirer. In June 2018 the talks escalate into a bidding competition with a telecommunications and media company; the sequence shows rival executive teams submitting proposals and reworking terms. The larger entertainment conglomerate raises its bid to seventy-one billion three hundred million dollars, and after internal deliberations the studio's board accepts the offer. The acquisition process moves through regulatory reviews and final approvals, and on March 20, 2019 the transaction concludes: the acquiring corporation finalizes the purchase and transfers ownership of the studio's film rights to its new parent and affiliated film studio.

After the acquisition closes, the film portrays the practical consequences for the franchise. The new corporate owners take inventory of preexisting development slates, and executives cancel the majority of planned adaptations that the previous management had greenlit. Rights to the franchise and its associated characters move into the portfolio of the acquiring company and its cinematic universe brand. Studio teams reassess the continuity and integration of these properties, and senior executives announce that future films involving those characters will be developed as part of the acquiring company's shared cinematic universe.

Throughout the chronology the film intercuts production footage, rehearsal-room tensions, and promotional events. It shows the writers and directors attending press junkets, negotiating with studio notes teams, and adjusting shooting schedules when cast members accept other commitments. It follows a particular arc of projects from conception through completion: the early 2000s attempt to graft the heroine's epic into a franchise installment, the reinvigoration and standalone development of a different singular antihero in the mid-2010s, the troubled production of a teenage-horror entry in 2017, and the protracted, expensive production and release of a condensed, single-feature origin story for the cosmic-power heroine in 2019. The film shows how mandated creative decisions--compressing a two-part narrative into a single film, insisting on specific rewrites, and ordering reshoots--shape the final versions that reach theaters. It documents the scheduling consequences of reshoots that require cast members to rearrange commitments and cause prolonged delays in release calendars.

No on-screen character deaths occur among the filmmakers, producers, or primary cast during the chain of events depicted; the film shows personnel departures, firings, and contract changes but does not depict fatal violence. The narrative records career shifts: directors leave projects, writers are reassigned, and actors move between promotional obligations and other productions, yet none of these personnel changes are portrayed as lethal.

In the final sequences the film assembles archival press conferences, theatrical posters, and box-office tallies on editing-room monitors. It shows the studio announcing release dates and then pushing them back while reshoots and corporate transactions proceed. After the acquisition finalizes in March 2019, executives in the acquiring company's offices put a line through planned projects and redirect resources to unify the characters into their in-house universe. The closing shots portray the franchise's title treatments dissolving into the acquiring studio's logo; the last images show studio executives approving integration plans and preparing new development documents that list the formerly separate characters as future entries within a cohesive cinematic slate. The film ends with those executives in a boardroom, signing off on the transition and closing the file on the previous studio's independent slate, leaving the projects that had been in various stages of development either canceled or folded into the acquiring company's long-term plans.

The ending follows the exhausted surviving legionnaires as they keep moving through the jungle toward the Chinese border, with Janicki trying to hold the group together until the journey finally breaks them. The film ends on survival carried to its limit, with the survivors reaching the edge of escape only after losing most of their number.

The final stretch begins with the unit already worn down by hunger, thirst, illness, and fear. Janicki is still leading the men, but by this point the march is no longer a controlled withdrawal; it is a desperate struggle to keep anyone alive long enough to see the allied side of the border. The jungle remains wet, oppressive, and hostile, and every movement costs the men more strength than they seem to have left.

As the group pushes onward, the tension that has been building throughout the journey narrows into a few final, bitter choices. The men who are still able to walk do so with shaking legs and hollow faces, carrying the last weight of their rifles and packs as if those objects have become part of their bodies. Janicki remains focused on the route and on keeping the unit moving, while the others are reduced to following him step by step, driven less by hope than by sheer refusal to die where they stand.

The ending does not turn into a clean victory. It closes on the cost of the escape itself: the journey has stripped the men down physically and emotionally, and the survivors arrive changed by what they have endured. Janicki's fate is to remain the central survivor among the group, still standing as the one who carried the others as far as he could. The other main men who make it to the end survive only by enduring the collapse of the unit around them, while those who cannot continue are left behind by death, collapse, or the jungle itself.

No. I could not verify any post-credits or mid-credits scene for The Last Men (2023) from the available results, and the search results you provided do not contain any reliable coverage of that film's end credits. The results that do mention "The Last Men" are about unrelated X-Men material, not the 2023 film.

If you want, I can help confirm whether there is a credits sting by checking alternate title spellings, original-language listings, or the film's end-credits structure.

The film centers on a group of French soldiers from the Foreign Legion who are trying to survive after being defeated in French Indochina in 1945. The cast listings identify key figures such as Caporal Lisbonne, Adjudant Janiçki, Giuseppe Sottile dit Lemiotte, Aubrac, Trefeuil dit Sorbonne, Volman dit Poussin, Tinh, and Mathusalem.

Caporal Lisbonne is one of the central soldiers named in the film's cast and is part of the stranded unit struggling through the jungle after the Japanese defeat of the French forces. The story follows him as one of the men forced into survival under collapsing military conditions.

Adjudant Janiçki is another major soldier in the group, listed prominently among the principal characters. He belongs to the surviving unit at the center of the film's jungle journey, making him one of the figures whose choices and endurance shape the group's fate.

Giuseppe Sottile dit Lemiotte is one of the named foreign soldiers in the film's ensemble and travels with the others through the jungle after their defeat. He is part of the same desperate survivor group, sharing the physical hardship, fear, and uncertainty that bind the men together.

Other named characters listed for the film include Aubrac, Trefeuil dit Sorbonne, Volman dit Poussin, Tinh, Mathusalem, Pepelucci dit Musso, Stigmann, and Marly. These names indicate a large ensemble of soldiers and fellow travelers surrounding the central survival narrative.

The Last Men (2023) does not appear to be especially family-friendly for younger children, and it is more suited to teens or adults. Based on the available ratings, it was given "Tous publics avec avertissement" in France and a 16+ rating in Germany, which suggests some material may be upsetting or too intense for children.

Potentially objectionable or upsetting elements for kids or sensitive viewers may include:

• War violence and survival peril in a World War II jungle setting, with soldiers struggling against enemy forces and harsh conditions.
• Intense threat and distress related to being hunted, trapped, or trying to survive in a dangerous environment.
• Alcohol-related content, since the soldiers are described as being weakened by alcohol and disease, and the film centers on exhausted adult combatants.
• A generally grim, bleak tone that may be emotionally heavy rather than light or uplifting.

I do not see evidence in the provided sources of explicit sex, graphic nudity, or strong profanity for this film specifically, but the war setting alone and the age ratings indicate it is not ideal for young children.